We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
34.51%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$81B
AUM Growth
+$1.17B
(+1.5%)
Cap. Flow
-$2.37B
Cap. Flow
% of AUM
-2.92%
Top 10 Holdings %
Top 10 Hldgs %
26.64%
Holding
1,562
New
88
Increased
546
Reduced
606
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$258M |
| 2 |
Brookfield Asset Management
BAM
|
+$211M |
| 3 |
Atlassian
TEAM
|
+$197M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$190M |
| 5 |
Progressive
PGR
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$396M |
| 2 |
Tesla
TSLA
|
+$335M |
| 3 |
Amazon
AMZN
|
+$310M |
| 4 |
Brookfield
BN
|
+$284M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.44% |
| 2 | Technology | 17.09% |
| 3 | Healthcare | 11.75% |
| 4 | Industrials | 8.45% |
| 5 | Energy | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Sana Biotechnology
SANA
$871M
| $530K | ﹤0.01% |
134,226
+12,200
| +10% | +$59.7K |
|
1277
MakeMyTrip
MMYT
$5.36B
| $530K | ﹤0.01% |
19,219
-1,303
| -6% | -$37.6K |
|
1278
Kimbell Royalty Partners
KRP
$1.48B
| $512K | ﹤0.01% |
+30,640
| New | +$538K |
|
|
MOR
1279
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $509K | ﹤0.01% |
+142,268
| New | +$636K |
|
1280
Lennox International
LII
$14.4B
| $508K | ﹤0.01% |
2,124
+20
| +1% | +$4.9K |
|
|
SVFB
1281
DELISTED
SVF Investment Corp. 2 Class A Ordinary Shares
SVFB
| $504K | ﹤0.01% |
50,000
| – | – |
|
1282
Futu Holdings
FUTU
$14.7B
| $499K | ﹤0.01% |
12,284
-400
| -3% | -$19.5K |
|
1283
Enanta Pharmaceuticals
ENTA
$366M
| $498K | ﹤0.01% |
10,700
| – | – |
|
1284
ProPetro Holding
PUMP
$1.36B
| $495K | ﹤0.01% |
47,700
+5,300
| +13% | +$55.8K |
|
1285
Applied Industrial Technologies
AIT
$12.8B
| $492K | ﹤0.01% |
+3,900
| New | +$478K |
|
|
RETA
1286
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $491K | ﹤0.01% |
12,920
+984
| +8% | +$33.9K |
|
1287
The Bancorp
TBBK
$2.79B
| $488K | ﹤0.01% |
+17,200
| New | +$476K |
|
1288
Arrow Electronics
ARW
$11.1B
| $487K | ﹤0.01% |
4,654
-350
| -7% | -$36.1K |
|
1289
Regal Rexnord
RRX
$13.7B
| $485K | ﹤0.01% |
4,046
-272
| -6% | -$35.7K |
|
|
VERV
1290
DELISTED
Verve Therapeutics
VERV
| $481K | ﹤0.01% |
24,862
+11,320
| +84% | +$300K |
|
1291
Keros Therapeutics
KROS
$199M
| $480K | ﹤0.01% |
+10,000
| New | +$467K |
|
1292
LegalZoom.com
LZ
$1.35B
| $479K | ﹤0.01% |
61,906
| – | – |
|
1293
Nurix Therapeutics
NRIX
$2.41B
| $475K | ﹤0.01% |
43,259
| – | – |
|
1294
Dynatrace
DT
$12.9B
| $470K | ﹤0.01% |
12,279
-300
| -2% | -$10.9K |
|
1295
Park National Corp
PRK
$3.76B
| $464K | ﹤0.01% |
3,300
| – | – |
|
1296
Orchestra BioMed
OBIO
$238M
| $463K | ﹤0.01% |
46,339
| – | – |
|
|
DCBO
1297
Docebo
DCBO
$525M
| $458K | ﹤0.01% |
13,857
+356
| +3% | +$10.7K |
|
1298
Healthcare Realty
HR
$7.28B
| $457K | ﹤0.01% |
+23,700
| New | +$466K |
|
1299
DNOW Inc
DNOW
$2.58B
| $447K | ﹤0.01% |
35,200
+19,400
| +123% | +$235K |
|
1300
Genesco
GCO
$425M
| $446K | ﹤0.01% |
9,700
+2,000
| +26% | +$90.8K |
|
Similar funds
VAM
TD Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, TD Asset Management held 1,562 positions worth $81B, up 1.5% from $79.9B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TD Asset Management's Q4 2022 filing shows 88 new, 546 increased, 606 reduced and 117 closed positions. Its largest new stake was Brookfield Asset Management: 7,008,054 shares worth $201M. The largest sale was Alphabet (Google) Class C, an estimated $396M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
- TD Asset Management's largest Q4 2022 buy was Brookfield Asset Management: 7,008,054 shares worth $201M.
- TD Asset Management added most to iShares MSCI Japan ETF in Q4 2022, an estimated $258M increase.
- TD Asset Management's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $396M.
- TD Asset Management fully exited Corcept Therapeutics in Q4 2022, selling an estimated $25.4M.
- TD Asset Management's ten largest holdings make up 27% of its $81B portfolio in Q4 2022.
- TD Asset Management opened 88 new positions and closed 117 in Q4 2022.
- TD Asset Management's portfolio value rose 1.5% quarter-over-quarter to $81B.
Based on TD Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.